Saad Usmani, MD

Video content above is prompted by the following: When did you first hear the term “late-line,” and how was it explained to you? Source link Saad Usmani, MD

Video content above is prompted by the following: How many different treatment regimens have you received since your diagnosis, and what have been your biggest challenges in coping with multiple relapses? Source link Saad Usmani, MD

Video content above is prompted by the following: How do you decide between different treatment approaches, such as bispecific antibodies (BCMA/GPRC5D), CAR T-cell therapy or other targeted treatments? What are the differences in effectiveness, side effects and accessibility between these

Opinion Video March 24, 2025 Panelists discuss how patient involvement in multiple myeloma treatment decisions has evolved from a physician-directed approach to a collaborative partnership, with many patients now actively participating through researching options, joining support groups, asking questions about

Opinion Video March 24, 2025 Panelists discuss how managing the logistics of multiple myeloma treatment often requires a comprehensive support network, with patients describing complex arrangements for travel to specialized cancer centers, securing temporary lodging near treatment facilities, coordinating caregiver

Video content above is prompted by the following: Can you briefly summarize key findings from clinical trials recently presented that are relevant to late-line RRMM? Source link Saad Usmani, MD

Opinion Video March 24, 2025 Panelists discuss how ciltacabtagene autoleucel (cilta-cel) demonstrates superior outcomes compared to real-world physician’s choice of therapy in patients with late-line relapsed/refractory multiple myeloma (RRMM), with significantly higher response rates, deeper remissions, longer progression-free survival and

Opinion Video March 24, 2025 Panelists discuss how balancing treatment effectiveness with quality of life in late-line multiple myeloma therapy requires a highly personalized approach, with patients and physicians collaboratively weighing factors such as potential for deeper or longer remissions

Opinion Video March 24, 2025 Panelists discuss how quality of life priorities shift in late-line multiple myeloma treatment, with patients emphasizing the importance of maintaining independence in daily activities, preserving cognitive function, managing pain effectively, minimizing treatment-related side effects that

Opinion Video March 24, 2025 Panelists discuss how lifestyle modifications have become crucial coping strategies for managing multiple myeloma symptoms and treatment side effects, with patients reporting benefits from structured exercise regimens tailored to their energy levels, anti-inflammatory dietary approaches,